Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
2.010
-0.070 (-3.37%)
At close: Feb 27, 2026, 4:00 PM EST
1.970
-0.040 (-1.99%)
After-hours: Feb 27, 2026, 6:57 PM EST
Alzamend Neuro Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Oct '25 Oct 31, 2025 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 |
| Selling, General & Admin | 3.06 | 3.08 | 3.48 | 7.42 | 7.12 | 3.64 | |
| Research & Development | 2.81 | 1.41 | 6.46 | 7.45 | 5.2 | 1.31 | |
| Operating Expenses | 5.87 | 4.5 | 9.94 | 14.87 | 12.32 | 4.95 | |
| Operating Income | -5.87 | -4.5 | -9.94 | -14.87 | -12.32 | -4.95 | |
| Interest Expense | -0.01 | -0.02 | -0.01 | -0.01 | -0.05 | -0.16 | |
| Interest & Investment Income | - | - | - | - | - | 0 | |
| EBT Excluding Unusual Items | -5.88 | -4.51 | -9.95 | -14.88 | -12.37 | -5.11 | |
| Other Unusual Items | - | - | - | - | 0 | 0.06 | |
| Pretax Income | -5.88 | -4.51 | -9.95 | -14.88 | -12.36 | -5.05 | |
| Net Income | -5.88 | -4.51 | -9.95 | -14.88 | -12.36 | -5.05 | |
| Preferred Dividends & Other Adjustments | 0.59 | 0.59 | - | - | - | - | |
| Net Income to Common | -6.47 | -5.11 | -9.95 | -14.88 | -12.36 | -5.05 | |
| Shares Outstanding (Basic) | 2 | 0 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 2 | 0 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 985.74% | 499.67% | 4.07% | 9.45% | 22.64% | 1.96% | |
| EPS (Basic) | -3.76 | -11.32 | -132.33 | -205.97 | -187.31 | -93.78 | |
| EPS (Diluted) | -3.76 | -11.32 | -132.33 | -205.97 | -187.31 | -93.78 | |
| Free Cash Flow | -5.86 | -6.87 | -8.42 | -8.92 | -6.72 | -2.71 | |
| Free Cash Flow Per Share | -3.40 | -15.24 | -111.97 | -123.53 | -101.83 | -50.40 | |
| EBITDA | -5.79 | -4.45 | -9.89 | -14.85 | -12.32 | - | |
| D&A For EBITDA | 0.08 | 0.05 | 0.05 | 0.02 | 0 | - | |
| EBIT | -5.87 | -4.5 | -9.94 | -14.87 | -12.32 | -4.95 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.